Key result
Reticulated platelets are young, hyper-reactive platelets that correlate with insufficient antiplatelet response and are promising biomarkers for predicting adverse cardiovascular events.
Why the study?
The reasons for the intrinsic hyper-reactivity of reticulated platelets and their association with ischemic events remain incompletely understood.
Design
Structured review of preclinical and clinical findings
Loading...
These biomarkers should not yet change routine antiplatelet prescribing; leaves open whether targeting reticulated.
Reticulated platelets are hyper-reactive and may serve as novel biomarkers for predicting adverse cardiovascular events and insufficient antiplatelet response.
A 2022 study conducted a review in Cardiovascular disease. Reticulated platelets (RPs) was evaluated. Reticulated platelets are young, hyper-reactive platelets that correlate with insufficient antiplatelet response and are promising biomarkers for predicting adverse cardiovascular events.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: